A Cheap Investor Case Study on a 90% Win

Over the last few years, we’ve watched small-cap stocks explode. ACADIA Pharmaceuticals (ACAD) skyrocketed 4,851% Arena Pharmaceuticals (ARNA) shot up 878% Nautilus (NLS) rocketed 1,523% Pacific Biosciences (PACB) soared 1,020% Horizon Pharmaceuticals (HZNP) flew 1,737% In many cases, Wall Street wrongly ignored those stocks when they were selling at attractive low prices, even though they…

Details